These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34745966)

  • 21. MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer.
    Zhao S; Hou D; Zheng X; Song W; Liu X; Wang S; Zhou L; Tao X; Lv L; Sun Q; Jin Y; Ding L; Mao L; Wu N
    Transl Lung Cancer Res; 2021 Jan; 10(1):368-380. PubMed ID: 33569319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of
    Luo Y; Huang Z; Gao Z; Wang B; Zhang Y; Bai Y; Wu Q; Wang M
    Korean J Radiol; 2024 Feb; 25(2):189-198. PubMed ID: 38288898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy.
    Chang R; Qi S; Wu Y; Yue Y; Zhang X; Qian W
    Cancer Imaging; 2023 Oct; 23(1):101. PubMed ID: 37867196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
    Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
    Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of contrast-enhanced magnetic resonance imaging-T2WI-based radiomic features in distinguishing lung adenocarcinoma from lung squamous cell carcinoma with solid components >8 mm.
    Yang M; Shi L; Huang T; Li G; Shao H; Shen Y; Zhu J; Ni B
    J Thorac Dis; 2023 Feb; 15(2):635-648. PubMed ID: 36910079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CT-based radiomics signature analysis for evaluation of response to induction chemotherapy and progression-free survival in locally advanced hypopharyngeal carcinoma.
    Liu X; Long M; Sun C; Yang Y; Lin P; Shen Z; Xia S; Shen W
    Eur Radiol; 2022 Nov; 32(11):7755-7766. PubMed ID: 35608663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab.
    Jazieh K; Khorrami M; Saad A; Gad M; Gupta A; Patil P; Viswanathan VS; Rajiah P; Nock CJ; Gilkey M; Fu P; Pennell NA; Madabhushi A
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35256515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a radiomics-based nomogram for the prediction of postoperative malnutrition in stage IB1-IIA2 cervical carcinoma.
    Yu W; Xu H; Chen F; Shou H; Chen Y; Jia Y; Zhang H; Ding J; Xiong H; Wang Y; Song T
    Front Nutr; 2023; 10():1113588. PubMed ID: 36819703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of
    Yang B; Ji H; Zhong J; Ma L; Zhong J; Dong H; Zhou C; Duan S; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
    Front Oncol; 2020; 10():567160. PubMed ID: 33262942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
    Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
    Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Xu X; Sun X; Ma L; Zhang H; Ji W; Xia X; Lan X
    Front Oncol; 2023; 13():1149791. PubMed ID: 36969043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of UTE-MRI-based radiomics model for prediction of histopathologic subtype of lung adenocarcinoma: in comparison with CT-based radiomics model.
    Lee S; Lee CY; Kim NY; Suh YJ; Lee HJ; Yong HS; Kim HR; Kim YJ
    Eur Radiol; 2024 May; 34(5):3422-3430. PubMed ID: 37840100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.
    Sun Y; Li C; Jin L; Gao P; Zhao W; Ma W; Tan M; Wu W; Duan S; Shan Y; Li M
    Eur Radiol; 2020 Jul; 30(7):3650-3659. PubMed ID: 32162003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
    Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
    Front Oncol; 2022; 12():894323. PubMed ID: 35800046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel radiomic signature as a prognostic biomarker for locally advanced rectal cancer.
    Meng Y; Zhang Y; Dong D; Li C; Liang X; Zhang C; Wan L; Zhao X; Xu K; Zhou C; Tian J; Zhang H
    J Magn Reson Imaging; 2018 Feb; ():. PubMed ID: 29437271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiomic signature of
    Jiang Y; Yuan Q; Lv W; Xi S; Huang W; Sun Z; Chen H; Zhao L; Liu W; Hu Y; Lu L; Ma J; Li T; Yu J; Wang Q; Li G
    Theranostics; 2018; 8(21):5915-5928. PubMed ID: 30613271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can CT Radiomics Detect Acquired T790M Mutation and Predict Prognosis in Advanced Lung Adenocarcinoma With Progression After First- or Second-Generation EGFR TKIs?
    Yang X; Fang C; Li C; Gong M; Yi X; Lin H; Li K; Yu X
    Front Oncol; 2022; 12():904983. PubMed ID: 35875167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiomic Features Associated With HPV Status on Pretreatment Computed Tomography in Oropharyngeal Squamous Cell Carcinoma Inform Clinical Prognosis.
    Song B; Yang K; Garneau J; Lu C; Li L; Lee J; Stock S; Braman NM; Koyuncu CF; Toro P; Fu P; Koyfman SA; Lewis JS; Madabhushi A
    Front Oncol; 2021; 11():744250. PubMed ID: 34557418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors.
    Zhu C; Ding J; Wang S; Qiu Q; Ji Y; Wang L
    Thorac Cancer; 2021 Dec; 12(23):3110-3120. PubMed ID: 34647417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.